Skip to main content
C

CELLUMED CO., LTD. — Investor Relations & Filings

Ticker · 049180 ISIN · KR7049180003 KO Manufacturing
Open in API
Filings indexed 396 across all filing types
Latest filing 2021-02-17 Major Shareholding Noti…
Country KR South Korea
Listing KO 049180

About CELLUMED CO., LTD.

http://www.clnzyme.co.kr/

CELLUMED CO., LTD. is a biotechnology company specializing in the development and manufacturing of medical devices, tissue grafts, and advanced biologics. The company operates as a human tissue bank, producing and supplying a variety of bone graft materials, including allografts and xenografts, for transplantation. Its medical device portfolio features orthopedic implants, with a key product being an artificial knee joint system. In the biologics sector, Cellumed develops growth factors and provides specialized enzymes, such as CLnZyme, which are utilized in the research, development, and production of RNA-based vaccines and therapeutics.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically a 3rd party capital increase) by a major shareholder (Inscobee) and its special related parties in the company Cellumed. This falls under the category of Major Shareholding Notification.
2021-02-17 Korean
기타시장안내(개선기간 종료에 따른 상장폐지여부 결정 안내)
Delisting Announcement Classification · 1% confidence The document is a short regulatory notice from the Korea Exchange regarding the status of Cellumed's listing following the expiration of an improvement period. It outlines the timeline for submission of documents and the subsequent review process by the Corporate Review Committee. As it is a regulatory announcement regarding listing status and does not fit into specific categories like delisting (which hasn't happened yet) or financial reports, it falls under the general regulatory filing category.
2021-02-15 Korean
주요사항보고서(타법인주식및출자증권양수결정)
M&A Activity Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange regarding the acquisition of shares in another company (타법인 주식 및 출자증권 양수결정). This type of regulatory filing is a mandatory disclosure for material corporate events in the Korean market. Since it does not fit into specific categories like M&A (which usually implies a merger or takeover bid) or other specialized categories, it falls under the general regulatory filing category.
2021-02-09 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a 'Capital Increase' (유상증자결정) for the company Cellumed. It details the issuance of new shares, the purpose of the capital raise (operating funds, debt repayment), and the list of third-party allottees. This type of filing, which announces changes to capital structure and share issuance, falls under the 'Share Issue/Capital Change' category.
2021-02-08 Korean
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change Classification · 1% confidence The document is a formal announcement regarding the results of a third-party capital increase (share issuance) by Cellumed. It details the number of shares issued, the total amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2021-02-08 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) from a Korean company (Cellumed) detailing a decision to issue new shares via third-party allocation (유상증자결정). This type of filing is a formal announcement of a capital change, specifically a share issuance, which falls under the 'Share Issue/Capital Change' category.
2021-02-01 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.